| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.3 | 0.04 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |